Gene Editing: How much justice delayed or denied?
By Nicholas G. Evans,
Impact Ethics
| 12. 02. 2015
The International Summit on Human Gene Editing: A Global Discussion is a three-day event convened by the Chinese Academy of Sciences, The Royal Society, the United States (US) National Academy of Sciences, and US National Academy of Medicine. The Summit has a live webcast, a vibrant Twitter hashtag, and is being reported by major news organizations and blogs alike.
I want to pick up on one very small piece of this immense puzzle, highlighted by philosopher John Harris in the penultimate session of day one of the Summit (you can find his talk here). Harris, at the University of Manchester, highlighted three allegedly “obviously fallacious and dogmatic” arguments against the editing of the human genome:
- Arguments from the sacredness of the human genome;
- Arguments from the “unacceptable risks to future generations” as a result of human gene editing;
- The inability to get consent from children produced as a result of human gene editing.
I want to pick up the second of these, and concentrate solely on the question of editing the human genome in embryos, which is Harris’ main talking...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
Alice Wong, founder of the Disability Visibility Project, MacArthur Genius, liberationist, storyteller, writer, and friend of CGS, died on November 14. Alice shone a bright light on pervasive ableism in our society. She articulated how people with disabilities are limited not by an inability to do things but by systemic segregation and discrimination, the de-prioritization of accessibility, and the devaluation of their lives.
We at CGS learned so much from Alice about disability justice, which goes beyond rights...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...